155 related articles for article (PubMed ID: 29984257)
1. MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1.
Liu Q; Song Y; Duan X; Chang Y; Guo J
Biomed Res Int; 2018; 2018():9870693. PubMed ID: 29984257
[TBL] [Abstract][Full Text] [Related]
2. miR-139-mediated NOTCH1 regulation is crucial for the inhibition of osteosarcoma progression caused by resveratrol.
Xiao X; Zhang Y; Pan W; Chen F
Life Sci; 2020 Feb; 242():117215. PubMed ID: 31881225
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells.
Zhou X; Natino D; Zhai X; Gao Z; He X
Mol Med Rep; 2018 May; 17(5):7209-7217. PubMed ID: 29568877
[TBL] [Abstract][Full Text] [Related]
4. Roles of microRNA-22 in Suppressing Proliferation and Promoting Sensitivity of Osteosarcoma Cells via Metadherin-mediated Autophagy.
Wang P; Zhao ZQ; Guo SB; Yang TY; Chang ZQ; Li DH; Zhao W; Wang YX; Sun C; Wang Y; Feng W
Orthop Surg; 2019 Apr; 11(2):285-293. PubMed ID: 30932352
[TBL] [Abstract][Full Text] [Related]
5. MiR-34c inhibits osteosarcoma metastasis and chemoresistance.
Xu M; Jin H; Xu CX; Bi WZ; Wang Y
Med Oncol; 2014 Jun; 31(6):972. PubMed ID: 24802328
[TBL] [Abstract][Full Text] [Related]
6. microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis.
Yang D; Xu T; Fan L; Liu K; Li G
J Exp Clin Cancer Res; 2020 Sep; 39(1):201. PubMed ID: 32972441
[TBL] [Abstract][Full Text] [Related]
7. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
[TBL] [Abstract][Full Text] [Related]
8. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
[TBL] [Abstract][Full Text] [Related]
9. MiR-92a modulates proliferation, apoptosis, migration, and invasion of osteosarcoma cell lines by targeting Dickkopf-related protein 3.
Yu H; Song H; Liu L; Hu S; Liao Y; Li G; Xiao X; Chen X; He S
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30926679
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of miR-377 contributes to cisplatin resistance by targeting XIAP in osteosarcoma.
Liu XG; Xu J; Li F; Li MJ; Hu T
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1249-1257. PubMed ID: 29565481
[TBL] [Abstract][Full Text] [Related]
11. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
[TBL] [Abstract][Full Text] [Related]
12. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.
Zhou Y; Huang Z; Wu S; Zang X; Liu M; Shi J
J Exp Clin Cancer Res; 2014 Jan; 33(1):12. PubMed ID: 24468065
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
Jia F; Zhang Z; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-92a promotes the tumor growth of osteosarcoma by suppressing F-box and WD repeat-containing protein 7.
Jiang X; Li X; Wu F; Gao H; Wang G; Zheng H; Wang H; Li J; Chen C
Gene; 2017 Mar; 606():10-16. PubMed ID: 28069547
[TBL] [Abstract][Full Text] [Related]
15. Biological roles of microRNA-140 in tumor growth, migration, and metastasis of osteosarcoma in vivo and in vitro.
Gu R; Sun YF; Wu MF; Liu JB; Jiang JL; Wang SH; Wang XL; Guo Q
Tumour Biol; 2016 Jan; 37(1):353-60. PubMed ID: 26219893
[TBL] [Abstract][Full Text] [Related]
16. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1.
Yan H; Zhang B; Fang C; Chen L
Anticancer Drugs; 2018 Jun; 29(5):440-448. PubMed ID: 29494357
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
Cheng FH; Zhao ZS; Liu WD
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
[TBL] [Abstract][Full Text] [Related]
18. Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway.
Wang Y; Shang G; Wang W; Qiu E; Pei Y; Zhang X
Life Sci; 2020 Sep; 256():117967. PubMed ID: 32553931
[TBL] [Abstract][Full Text] [Related]
19. Lupeol inhibits osteosarcoma progression by up-regulation of HMGA2 via regulating miR-212-3p.
Zhong J; He C; Xu F; Xu X; Liu L; Xu M; Guo Z; Wang Y; Liao J; Li Y
J Orthop Surg Res; 2020 Sep; 15(1):374. PubMed ID: 32883329
[TBL] [Abstract][Full Text] [Related]
20. Positive feedback loop SP1/MIR17HG/miR-130a-3p promotes osteosarcoma proliferation and cisplatin resistance.
Meng Y; Hao D; Huang Y; Jia S; Zhang J; He X; Sun L; Liu D
Biochem Biophys Res Commun; 2020 Jan; 521(3):739-745. PubMed ID: 31706574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]